The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy.
 
Soo Jung Lee
No Relationships to Disclose
 
Shidong Jia
No Relationships to Disclose
 
Pan Du
Employment - Predicine
Leadership - Predicine
Stock and Other Ownership Interests - Predicine
 
Jeeyeon Lee
No Relationships to Disclose
 
Byeongju Kang
No Relationships to Disclose
 
In Hee Lee
No Relationships to Disclose
 
Yee Soo Chae
No Relationships to Disclose
 
Ho Yong Park
No Relationships to Disclose
 
Jee-Young Nora Park
No Relationships to Disclose
 
Liam IL Young Chung
No Relationships to Disclose
 
Tiantian Zheng
No Relationships to Disclose
 
Lu Tan
No Relationships to Disclose
 
Young Kwang Chae
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Foundation Medicine; Guardant Health; Immuneoncia; Lilly; Lunit; Roche/Genentech; Takeda; Tempus
Speakers' Bureau - AstraZeneca; BMS; G1 Therapeutics; Genentech/Roche; Jazz Pharmaceuticals; Lilly; Merck
Research Funding - Abbvie; Biodesix; Bristol-Myers Squibb; Freenome; Lexent Bio